NCT01431456View on ClinicalTrials.gov

Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery

PHASE3CompletedINTERVENTIONAL

Enrollment

148

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions

Venous Thromboembolism

Interventions

DRUG

Dabigatran

DRUG

Rivaroxaban

DRUG

Nadroparin

Trial Locations (1)

Unknown

Martini Ziekenhuis, Groningen

All Listed Sponsors

lead

Martini Hospital Groningen

OTHER

NCT01431456 - Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery | Biotech Hunter | Biotech Hunter